Hamartomas are noncancerous growths made up of normal cells that have grown in a disorganized way. Unlike a tumor that produces abnormal cells, a hamartoma contains the same types of cells you’d find in the surrounding tissue, just arranged haphazardly and growing out of proportion. They can appear in almost any organ, from the lungs and brain to the kidneys, skin, and breast. Most are discovered by accident during imaging for something else entirely, and many never cause symptoms or require treatment.
How Hamartomas Differ From Tumors
The key distinction is what’s inside them. Under a microscope, hamartoma cells look normal. They’re the same cell types native to whatever organ they’re growing in, just piled together without the usual organized architecture. You might see fat cells, cartilage cells sitting in their normal supportive matrix, and other tissue types specific to the site. There’s no sign of the aggressive features that define cancer: no invasion into surrounding tissue and no spread to distant organs.
This also separates hamartomas from a related concept called a choristoma, which is a growth of normal cells found in the wrong location entirely (like a pocket of pancreatic tissue appearing in the stomach wall). Hamartomas are made of the right cells in the right place. They’re just growing in a jumbled, excessive pattern.
Whether hamartomas are true tumors or developmental malformations has been debated for decades. Some behave more like birth defects that grow along with the child, while others appear later in life and grow slowly on their own. In practice, the distinction rarely changes how they’re managed.
Where Hamartomas Commonly Appear
Lungs
Lung hamartomas are the most common benign lung tumor, with an incidence between 0.025% and 0.32% of the population. They account for about 8% of solitary pulmonary nodules found on chest scans and a full 75% of benign lung nodules. Most are small, round, and sit in the outer edges of the lung where they cause no symptoms. The classic giveaway on a CT scan is a “popcorn calcification” pattern, though this only shows up in about 10% of cases. Fat density within the nodule, visible in roughly 36% of cases, is another reliable indicator. When neither feature is present, distinguishing a lung hamartoma from a small cancer can require a biopsy.
Brain (Hypothalamus)
Hypothalamic hamartomas are rare growths attached to the base of the brain near a structure called the hypothalamus, which regulates hormones, body temperature, and other automatic functions. These are especially significant in children because they can trigger a distinctive type of seizure called a gelastic seizure, which looks like sudden, uncontrollable bursts of laughter. These episodes typically begin in early infancy.
The hamartoma itself is the seizure source. Small neurons within the growth have pacemaker-like firing behavior, generating electrical activity on their own. Some of these neurons also respond abnormally to the brain’s main calming chemical signal, becoming more active rather than less active when exposed to it. The location where the hamartoma attaches to the brain, particularly near the mammillary bodies in the posterior hypothalamus, appears to matter more than its size in determining whether seizures develop. Surgical removal of the hamartoma can stop gelastic seizures immediately in most patients.
On CT imaging, these growths appear the same density as surrounding brain tissue and don’t light up with contrast dye, which helps distinguish them from brain tumors that typically show enhancement and change over time.
Breast
Breast hamartomas (sometimes called fibroadenolipomas) produce one of the more recognizable patterns in medical imaging. On a mammogram, they appear as a well-defined mass containing both fatty and dense soft tissue, wrapped in a thin capsule. This creates what radiologists call a “breast within a breast” appearance, because the mass essentially looks like a miniature version of normal breast tissue. They’re typically classified as BI-RADS 2, meaning benign, and don’t require further workup. Occasionally, a hamartoma rich in fibrous tissue can appear uniformly dense, making it harder to distinguish from a fibroadenoma.
Kidneys
Renal angiomyolipomas are kidney hamartomas composed of blood vessels, smooth muscle, and fat. They’re usually diagnosed on imaging when fat is visible within the mass on MRI, a finding that reliably separates them from kidney cancers. Most are small and harmless, but size matters here more than in other locations because larger ones carry a real risk of internal bleeding. The traditional threshold for concern is 4 cm, a cutoff established in 1986 and still used to guide management. More recent data suggests that 6.8 cm may be a more accurate predictor of hemorrhage, with 84.6% sensitivity. Notably, the smallest tumor observed to bleed in recent studies measured 4.1 cm, meaning anything under 4 cm appears genuinely safe to monitor.
Genetic Syndromes Linked to Hamartomas
A single hamartoma is usually a one-off finding. Multiple hamartomas, especially in different organs, can signal an inherited genetic condition. The most well-known is PTEN hamartoma tumor syndrome, caused by mutations in the PTEN gene that normally acts as a brake on cell growth.
This umbrella term covers several related conditions. Adults with PTEN mutations often present with Cowden syndrome, which involves hamartomas across multiple tissues and a significantly increased risk of breast cancer, thyroid cancer, and endometrial cancer. Children with the same gene mutation more commonly present with an unusually large head (macrocephaly), autism spectrum disorder, or a related condition called Bannayan-Riley-Ruvalcaba syndrome, which features lipomas, vascular malformations, and characteristic freckling on the genital skin.
Diagnosis of Cowden syndrome requires meeting a combination of major and minor criteria. Major criteria include breast cancer, follicular thyroid cancer, three or more gastrointestinal hamartomas, and a head circumference above the 97th percentile (58 cm in women, 60 cm in men). Minor criteria include colorectal cancer, autism spectrum disorder, intellectual disability, and kidney cancer. Meeting three or more major criteria, or two major plus three minor, establishes the diagnosis. Because of the elevated cancer risk, people identified with this syndrome undergo regular screening across multiple organs.
How Hamartomas Are Diagnosed
Most hamartomas are found incidentally on imaging performed for another reason. The diagnostic approach depends heavily on location. In the lungs, a combination of CT features like fat content and popcorn calcification can be enough. In the breast, the characteristic mammographic appearance often clinches the diagnosis without a biopsy. Kidney hamartomas are confirmed by demonstrating fat within the mass on MRI.
When imaging isn’t definitive, PET scans can help. Lung hamartomas typically show no or very low metabolic activity, in contrast to cancers, which light up with high metabolic signals. For nerve-based hamartomas, MRI can reveal a distinctive “coaxial cable” pattern where nerve fibers appear as dark tubes surrounded by bright fat within the nerve sheath.
The challenge arises when a hamartoma lacks its classic imaging features. A lung nodule without visible fat or calcification, a uniformly dense breast mass, or a kidney growth without obvious fat content may all require biopsy to rule out malignancy.
When Treatment Is Needed
The majority of hamartomas require nothing more than monitoring. A lung hamartoma that isn’t growing and has classic features on CT can simply be left alone. Breast hamartomas classified as BI-RADS 2 need no follow-up beyond routine screening. Small kidney hamartomas under 4 cm can be watched with periodic imaging.
Treatment becomes necessary when hamartomas cause symptoms or pose a risk of complications. Kidney hamartomas over 4 cm are typically treated with a procedure that blocks their blood supply or, in some cases, partial surgical removal, primarily to prevent dangerous bleeding. Hypothalamic hamartomas causing seizures that don’t respond to medication may require surgical resection, and newer techniques have made this safer and more effective. Gastrointestinal hamartomas, particularly those associated with genetic syndromes, may need endoscopic removal when they grow larger than 15 mm or cause bowel obstruction through a process called intussusception, where part of the intestine telescopes into an adjacent segment.
For people with PTEN hamartoma tumor syndrome, ongoing surveillance is the primary strategy. This involves coordinated screening for the associated cancers across multiple specialties, with the specific schedule tailored to which organs are at highest risk based on individual and family history.